General Archive
-
ArticlesLifeArc Pathfinder Award recipients uncover genetic cause of severe nerve condition in children
Researchers at the University of Manchester have identified a rare genetic mutation that causes severe nerve damage in children following mild infections. Their findings…
-
ArticlesLifeArc and Genetic Alliance UK launch a new report calling for the acceleration of research and development (R&D) for rare diseases
LifeArc and Genetic Alliance UK have launched a report calling for the UK Government, NHS, researchers, industry, patient groups and…
-
ArticlesLifeArc joins new global initiative to accelerate drug discovery for ALS/MND treatments
LifeArc joins new global initiative to accelerate drug discovery for ALS/MND treatments LifeArc has become a partner of the Longitude…
-
ArticlesLifeArc appoints new General Counsel and Company Secretary and Chief Communications Officer
We have appointed two new members to our executive team: Jan Lasik as our new General Counsel and Company Secretary,…
-
ArticlesLifeArc supports research to develop a quick, affordable blood test for the early detection of dementia
As part of a collaboration with UK Dementia Research Institute, we are supporting research to validate a new blood test…
-
Articles, News releasesLifeArc joins the REMEDi4ALL Consortium, a pioneering global platform shaping the future of drug repurposing
LifeArc and the EU-funded project, REMEDi4ALL, have announced a collaboration agreement to strengthen the partnership’s potential to transform and accelerate…
-
ArticlesLifeArc Ventures 2024: new investments, targeted follow-ons and substantive portfolio progress
LifeArc Ventures, which invests in innovative early-stage life science companies as part of LifeArc, today announced substantial progress in 2024,…
-
ArticlesClare Terlouw, Head of LifeArc Ventures, talks to In Vivo’s Ashley Yeo on the improving investment climate
“There is a lot of capital out there in biotech land that has been largely locked up. Companies are coming…
-
ArticlesBronchiectasis: an overlooked lung condition with untapped commercial and research potential
Bronchiectasis (BE) is a chronic lung condition that significantly impacts the lives of many people in the UK and around…
-
ArticlesThe new LifeArc identity: More than just a fresh coat of paint
In the world of medical research, it’s vital that we keep challenging ourselves to push forwards. We’ve created a new…
-
ArticlesLifeArc Translational Science Summit: Highlights and key takeaways
The first ever LifeArc Translational Science Summit was a resounding success! Held on 23 April in London, the event brought…
-
Articles6 challenges in rare disease research and how we can overcome them
Rare conditions, individually, have low patient numbers. However, with more than 7,000 rare diseases identified, collectively there are millions of…